We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Morningstar
MORN
$6.56B
| $318K | ﹤0.01% |
4,066
| – | – |
|
952
West Pharmaceutical
WST
$23.1B
| $317K | ﹤0.01% |
3,900
| – | – |
|
|
IFX
953
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
| $316K | ﹤0.01% |
15,471
-2,824
| -15% | -$57.7K |
|
|
ITCI
954
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $315K | ﹤0.01% |
19,410
| – | – |
|
955
Hackett Group
HCKT
$245M
| $314K | ﹤0.01% |
+16,124
| New | +$290K |
|
956
HSBC
HSBC
$355B
| $314K | ﹤0.01% |
8,556
-6,456
| -43% | -$243K |
|
957
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
| $314K | ﹤0.01% |
7,239
-2,295
| -24% | -$97.9K |
|
958
Qorvo
QRVO
$7.63B
| $313K | ﹤0.01% |
4,585
-193
| -4% | -$12.4K |
|
959
Fidelity National Information Services
FIS
$21.5B
| $312K | ﹤0.01% |
3,931
-3,905
| -50% | -$314K |
|
|
SHLX
960
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $312K | ﹤0.01% |
9,700
| – | – |
|
961
Marriott Vacations Worldwide
VAC
$3.24B
| $310K | ﹤0.01% |
+3,115
| New | +$280K |
|
|
NS
962
DELISTED
NuStar Energy L.P.
NS
| $310K | ﹤0.01% |
6,000
+38
| +0.6% | +$2K |
|
963
Martin Marietta Materials
MLM
$33.6B
| $309K | ﹤0.01% |
1,417
+365
| +35% | +$80.5K |
|
|
HIT
964
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
| $308K | ﹤0.01% |
5,713
+2,451
| +75% | +$132K |
|
965
Agnico Eagle Mines
AEM
$72.6B
| $307K | ﹤0.01% |
7,254
+1,449
| +25% | +$65.1K |
|
966
WEX
WEX
$6.11B
| $306K | ﹤0.01% |
2,960
+779
| +36% | +$86.5K |
|
967
Dentsply Sirona
XRAY
$2.59B
| $305K | ﹤0.01% |
4,898
+442
| +10% | +$26.6K |
|
968
ZTO Express
ZTO
$18.2B
| $305K | ﹤0.01% |
23,311
+12,807
| +122% | +$166K |
|
|
BERY
969
DELISTED
Berry Global Group, Inc.
BERY
| $305K | ﹤0.01% |
6,848
-122
| -2% | -$5.61K |
|
|
FNSR
970
DELISTED
Finisar Corp
FNSR
| $305K | ﹤0.01% |
11,174
| – | – |
|
971
Helix Energy Solutions
HLX
$1.46B
| $304K | ﹤0.01% |
+39,212
| New | +$315K |
|
972
iShares Europe ETF
IEV
$1.63B
| $303K | ﹤0.01% |
7,250
| – | – |
|
973
iShares Global 100 ETF
IOO
$8.56B
| $302K | ﹤0.01% |
7,400
+6,926
| +1,461% | +$276K |
|
974
Brown-Forman Class A
BF.A
$12.3B
| $296K | ﹤0.01% |
7,873
| – | – |
|
|
CAJ
975
DELISTED
Canon, Inc.
CAJ
| $296K | ﹤0.01% |
9,482
-8,436
| -47% | -$250K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.